Literature DB >> 31163134

An Association Between Large Optic Nerve Cupping and Cognitive Function.

Thasarat Sutabutr Vajaranant1, Joelle Hallak2, Mark A Espeland3, Louis R Pasquale4, Barbara E Klein5, Stacy M Meuer5, Stephen R Rapp6, Mary N Haan7, Pauline M Maki8.   

Abstract

PURPOSE: To determine if a larger cup-to-disc ratio is associated with poor cognitive function in postmenopausal women without glaucoma or ocular hypertension.
METHODS: We used data from the Women's Health Initiative (WHI) hormone trial, originally designed to test effects of hormone therapy (HT) on various health outcomes. Large cup-to-disc ratio was defined as greater than 0.6 in either eye based on stereoscopic optic nerve photographs. Global cognitive function was assessed annually by Modified Mini-Mental State Examination (3MSE) in the WHI Memory Study. Exclusions were no information on optic nerve grading; no 3MSE scores at the time of the eye examination, ocular hypertension (intraocular pressure >23 mm Hg, Goldmann applanation tonometry), or glaucoma medication use. A generalized linear model for log-transformed 3MSE scores was used for determining the association between large cup-to-disc ratio and 3MSE scores, adjusting for age, race, diabetes, body mass index, cardiovascular disease, smoking, HT randomization, education, and diabetic retinopathy.
RESULTS: Analyses included 1636 women (mean age ± standard deviation, 69.57 ± 3.64 years; 90.39% white). Of those, 122 women had large cup-to-disc ratio. The mean 3MSE scores in women with vs without large cup-to-disc ratio were 95.4 ± 6 vs 96.6 ± 5. In the adjusted model, women with large cup-to-disc ratio had statistically significantly lower 3MSE scores, compared with those without large cup-to-disc ratio, yielding the predicted mean difference in 3MSE scores of 0.75 with a standard error of 0.05 units (P = .04).
CONCLUSIONS: Postmenopausal women who had large cup-to-disc ratio without glaucoma or ocular hypertension exhibited lower global cognitive function. Further investigation is warranted. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31163134      PMCID: PMC7775038          DOI: 10.1016/j.ajo.2019.05.019

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  50 in total

1.  Optical coherence tomography assessed retinal nerve fiber layer thickness in patients with Alzheimer's disease: a meta-analysis.

Authors:  Xue-Fei He; Yi-Ting Liu; Cheng Peng; Fan Zhang; Shi Zhuang; Jin-Song Zhang
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

2.  Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases.

Authors:  Shinji Yoneda; Hideaki Hara; Akira Hirata; Mikiko Fukushima; Yasuya Inomata; Hidenobu Tanihara
Journal:  Jpn J Ophthalmol       Date:  2005 Mar-Apr       Impact factor: 2.447

3.  Optic nerve damage in Alzheimer's disease.

Authors:  A A Sadun; C J Bassi
Journal:  Ophthalmology       Date:  1990-01       Impact factor: 12.079

4.  Determinants of optic disc characteristics in a general population: The Rotterdam Study.

Authors:  R S Ramrattan; R C Wolfs; J B Jonas; A Hofman; P T de Jong
Journal:  Ophthalmology       Date:  1999-08       Impact factor: 12.079

5.  Associations between primary open angle glaucoma, Alzheimer's disease and vascular dementia: record linkage study.

Authors:  Tiarnan D L Keenan; Raph Goldacre; Michael J Goldacre
Journal:  Br J Ophthalmol       Date:  2014-11-04       Impact factor: 4.638

Review 6.  Estrogen deficiency accelerates aging of the optic nerve.

Authors:  Thasarat S Vajaranant; Louis R Pasquale
Journal:  Menopause       Date:  2012-08       Impact factor: 2.953

7.  Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease.

Authors:  Pervin K Iseri; Ozgül Altinaş; Tomris Tokay; Nurşen Yüksel
Journal:  J Neuroophthalmol       Date:  2006-03       Impact factor: 3.042

8.  Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography.

Authors:  Ermengarda Marziani; Simone Pomati; Paola Ramolfo; Mario Cigada; Andrea Giani; Claudio Mariani; Giovanni Staurenghi
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-05       Impact factor: 4.799

9.  Prevalence of glaucoma in hospitalized older adults with Alzheimer's disease.

Authors:  Andrée-Anne Pelletier; Marie-Ève Théorět; Tanguy Boutin; Marie-Jeanne Kergoat; Fadi Massoud; Judith Latour; Céline Chayer; Hélène Kergoat
Journal:  Can J Neurol Sci       Date:  2014-03       Impact factor: 2.104

Review 10.  Application of Optical Coherence Tomography in the Detection and Classification of Cognitive Decline.

Authors:  Moon J Lee; Alison G Abraham; Bonnielin K Swenor; A Richey Sharrett; Pradeep Y Ramulu
Journal:  J Curr Glaucoma Pract       Date:  2018-03-01
View more
  1 in total

1.  Computed Tomography Density and β-Amyloid Deposition of Intraorbital Optic Nerve May Assist in Diagnosing Mild Cognitive Impairment and Alzheimer's Disease: A 18F-Flutemetamol Positron Emission Tomography/Computed Tomography Study.

Authors:  Han Wu; Zhe Lei; Yinghui Ou; Xin Shi; Qian Xu; Keqing Shi; Jing Ding; Qianhua Zhao; Xiuzhe Wang; Xiaolong Cai; Xueyuan Liu; Jingjing Lou; Xingdang Liu
Journal:  Front Aging Neurosci       Date:  2022-03-17       Impact factor: 5.750

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.